Provision looks back on 2016

Look back at 2016, ahead to the future


The year 2016 has been a year of significant progress for Provision, and one that will enable us to aggressively pursue our “mission of developing innovative healthcare solutions focused on improving patient care and clinical outcomes and developing support for research, education and charitable causes.” This year has also been a year which tested our commitment, courage and resolve—and we passed the test.

Here is a summary of some of our key developments…

  • The continuation of growth for our Provision CARES Proton Center in Knoxville and the treatment of more than 600 patients in 2016 and more than 1,300 patients since inception
  • The initiation and financing of the Scott Hamilton Proton Center and Comprehensive Cancer Center in Franklin, Tennessee. This will be our second Proton Center and Cancer Center. The facility will include a 45,000 square foot proton therapy clinical, research, and administrative facility and a 70,000 square foot medical office building for comprehensive cancer care which will include partnerships with Tennessee Oncology, Williamson Medical Center, Sarah Cannon Research Institute, and HCA.
  • The completion of a Joint Venture Agreement and the initiation of the Provision CARES Proton Center in Orlando, Florida, our first of many proton centers outside our State. We expect that a Provision CARES Cancer Center will also be developed at the same site as the Orlando proton center.
  • A $25 million investment in Provision by Neptunus and the formation of our Provision China joint venture which will be our base for the development of the China market. Additional investment in Provision by USA and China investors totaled more than $20 million.
  • Progress on the development of new Provision CARES Proton Centers and Cancer Centers in several locations in the USA, Europe, and Asia.
  • The FDA clearance of our new ProNova SC360 Proton Therapy System. “Achieving this milestone is an enormous accomplishment for our company and will allow us to offer the most advanced technology without compromising features for proton therapy treatment through systems that are smaller, lighter and easier to install while increasing capabilities compared to our competitors,” said Joe Matteo, President of ProNova Solutions. “The ProNova SC360 will not only improve proton therapy treatment, but due to its lower cost, will make proton therapy more accessible to patients worldwide.”